The board meeting of Transgene Biotek will be held on 03 September 2012 to approve the directors' report for the year ended 31 March 2012 and to fix the date for convening the 22nd Annual General Meeting of the company. The board will also consider the proposal for delisting the equity shares of the company from all the recognized Indian stock exchanges.